Sign In
Buy CRBP
$7.38
-0.160 (-2.12%)
At Close: Jun 03, 2026
Corbus Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Updates
08:05am, Thursday, 13'th May 2021
Norwood, MA, May 13, 2021 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical-stage drug development company pioneering transformat
Corbus Pharmaceuticals to Present at Three Upcoming Investor Conferences
08:05am, Tuesday, 11'th May 2021
Norwood, MA, May 11, 2021 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical-stage drug development company pioneering transformat
Corbus Pharmaceuticals (CRBP) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
03:47pm, Monday, 03'rd May 2021
Corbus Pharmaceuticals (CRBP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
4/20 Holiday Week Had These Cannabis Stocks Fired Up
01:05pm, Friday, 23'rd Apr 2021
Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week, and look ahead to how the cannabis industry will co
Norwood, MA, April 20, 2021 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical-stage drug development company pioneering transform
Corbus: Assessing If Lenabasum Can Finally Break Through
12:57pm, Thursday, 15'th Apr 2021
Top-line results are expected for Lenabasum in phase 3 for dermatomyositis shortly. Management believes an inflection point could be on the cards.
The Week Where New York Legalizes Recreational Marijuana
02:33pm, Thursday, 01'st Apr 2021
Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks last week, and look ahead to how the cannabis industry will co
Corbus Pharmaceuticals Reports Last Subject Visit in DETERMINE Phase 3 Study of Lenabasum for Treatment of Dermatomyositis
08:05am, Tuesday, 30'th Mar 2021
Norwood, MA, March 30, 2021 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical-stage drug development company pioneering transform
Corbus Pharmaceuticals (CRBP) Moves to Buy: Rationale Behind the Upgrade
01:16pm, Thursday, 18'th Mar 2021
Corbus Pharmaceuticals (CRBP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Corbus Pharmaceuticals Reports Fourth Quarter and Year-End 2020 Financial Results
07:05am, Monday, 15'th Mar 2021Earnings Previews: Corbus Pharmaceuticals, Yalla
01:07pm, Thursday, 11'th Mar 2021
As usual, no earnings reports are scheduled for release on Friday afternoon. And with just two weeks to go in the first calendar quarter of 2021, there are only two earnings reports that we think are
Corbus Pharmaceuticals to Present at Two Upcoming Investor Conferences
08:05am, Tuesday, 09'th Mar 2021
Norwood, MA, March 09, 2021 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical-stage drug development company pioneering transform
Corbus Pharmaceuticals to Report Fourth Quarter and Year-End 2020 Results on March 15, 2021
08:05am, Monday, 08'th Mar 2021
• Company to host conference call and webcast on Monday, March 15, 2021 at 8:30 a.m. ET
Corbus Pharmaceuticals (CRBP) May Report Negative Earnings: Know the Trend Ahead of Q4 Release
01:40pm, Thursday, 04'th Mar 2021
Corbus Pharmaceuticals (CRBP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
If January and February are a sign of things to come in 2021, traders and investors are going to make a lot of money this year. 4 hot small cap stocks on the move are Corbus Pharmaceuticals (NASDAQ: C
